Showing results (101-110 of 226) with videos related to
Sort By:
Pageof 23
Atherosclerosis|October 19, 2004
No APOEepsilon4 effect on coronary heart disease risk in a cohort with low smoking prevalence: the Whitehall II studyPhilippa J Talmud, Sarah J Lewis, Emma Hawe, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 1, 2009
APOE, CETP and LPL genes show strong association with lipid levels in Greek childrenM C Smart, G Dedoussis, E Louizou, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 8, 2003
Loci for CETP, LPL, LIPC, and APOC3 affect plasma lipoprotein size and sub-population distribution in Hispanic and non-Hispanic white subjects: the Columbia University BioMarkers StudyS E Humphries, L Berglund, C R Isasi, et al.Journal of Lipid Research|April 1, 1991
Characterization of a new apolipoprotein E5 variant detected in two French-Canadian subjectsF Mailly, C F Xu, M Xhignesse, et al.Clinical Chemistry and Laboratory Medicine|July 8, 2008
APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levelsJaroslav A Hubacek, Wu-Wei Wang, Zdena Skodová, et al.Atherosclerosis|January 28, 2006
Lp-PLA2 activity and PLA2G7 A379V genotype in patients with diabetes mellitusP T E Wootton, J W Stephens, S J Hurel, et al.Atherosclerosis|January 23, 2016
Post-GWAS methodologies for localisation of functional non-coding variants: ANGPTL3Federico Oldoni, Jutta Palmen, Claudia Giambartolomei, et al.BMJ (Clinical Research Ed.)|January 16, 2010
Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort studyPhilippa J Talmud, Aroon D Hingorani, Jackie A Cooper, et al.Atherosclerosis|August 12, 1998
The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography TrialS E Humphries, L A Luong, P J Talmud, et al.Annals of Human Genetics|November 4, 2005
The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4P J Talmud, J W Stephens, E Hawe, et al.Pageof 23